Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 | P08172 | 1/20 | 0.33 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.33 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.33 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.33 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.33 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.33 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | APEX1 | P27695 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 2/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6607573 | 0.71 | ALDH1A1 (0.35) | ALDH1A1 | |
| Bromide SCHEMBL8502372 | 0.70 | — | — | |
| SCHEMBL11060245 | 0.69 | TDP1 (0.34) | TDP1ALDH1A1HSD17B10 | |
| SCHEMBL11060249 | 0.69 | TDP1 (0.34) | TDP1ALDH1A1HSD17B10 | |
| SCHEMBL3085920 | 0.68 | — | — | |
| SCHEMBL10592789 | 0.68 | — | — | |
| SCHEMBL11094903 | 0.67 | TDP1 (0.33) | TDP1 | |
| SCHEMBL28818267 | 0.67 | — | — | |
| SCHEMBL19663841 | 0.67 | — | — | |
| SCHEMBL13324711 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021041278-A2 | COMPOSITIONS AND METHODS RELATING TO INSECTICIDES | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION (US) | 2021-03-04 | — | — | WO | disclosed |
| WO-2020198414-A1 | COMPOSITIONS AND METHODS RELATING TO INSECTICIDES | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION (US) | 2020-10-01 | — | — | WO | disclosed |
| EP-3709804-A1 | PESTICIDAL COMPOSITIONS AND RELATED METHODS | CJB Applied Technologies, LLC (US) | 2020-09-23 | — | — | EP | disclosed |
| US-20140162906-A1 | Pesticide Biomarker | NAGY JON OWEN (US) | 2014-06-12 | — | — | US | disclosed |
| US-20110166043-A1 | BIOMARKER DETECTION-2 | ATERIS TECHNOLOGIES, LLC | 2011-07-07 | — | — | US | disclosed |
| US-20100041077-A1 | PESTICIDE BIOMARKER | ATERIS TECHNOLOGIES, LLC | 2010-02-18 | — | — | US | disclosed |
| EP-2106257-A2 | COMPOSITIONS FOR PROVIDING COLOR TO ANIMATE OBJECTS AND RELATED METHODS | PPG Industries Ohio, Inc. (US) | 2009-10-07 | — | — | EP | disclosed |
| EP-1989209-A2 | ORGANIC COMPOUNDS | Novartis AG (CH) | 2008-11-12 | — | — | EP | disclosed |
| WO-2008091916-A2 | COMPOSITIONS FOR PROVIDING COLOR TO ANIMATE OBJECTS AND RELATED METHODS | PPG INDUSTRIES OHIO, INC. (US) | 2008-07-31 | — | — | WO | disclosed |
| EP-1945611-A1 | N- (HETERO) ARYL INDOLE DERIVATIVES AS PESTICIDES | Novartis Pharma AG (CH) | 2008-07-23 | — | — | EP | disclosed |
| WO-2001036372-A1 | ORGANIC COMPOUNDS AND THEIR USE IN THE CONTROL OF ECTOPARASITES | NOVARTIS AG (CH) | 2001-05-25 | — | — | WO | disclosed |
| WO-2001036415-A1 | PESTICIDAL AMINOHETEROCYCLAMIDE COMPOUNDS | NOVARTIS AG (CH) | 2001-05-25 | — | — | WO | disclosed |
| WO-2001015684-A2 | ANTIMYCOTIC DRUG | NOVARTIS AG (CH) | 2001-03-08 | — | — | WO | disclosed |
| WO-2000073310-A1 | 4-SUBSTITUTED MILBEMYCIN DERIVATIVES | NOVARTIS AG (CH) | 2000-12-07 | — | — | WO | disclosed |
| WO-2000058291-A1 | PESTICIDAL ENANTIOMER-PURE 2,4-DISUBSTITUTED OXAZOLINES | NOVARTIS AG (CH) | 2000-10-05 | — | — | WO | disclosed |
| WO-2000042047-A1 | 4-PHENOXYMETHYL-SUBSTITUTED MILBEMYCINS | NOVARTIS AG (CH) | 2000-07-20 | — | — | WO | disclosed |
| EP-0824314-A1 | EFFICACY ENHANCER FOR AGRICULTURAL CHEMICALS AND AGRICULTURAL CHEMICAL COMPOSITIONS | Kao Corporation (JP) | 1998-02-25 | — | — | EP | disclosed |
| WO-1997031527-A1 | EFFICACY ENHANCER FOR AGRICULTURAL CHEMICALS AND AGRICULTURAL CHEMICAL COMPOSITIONS | KAO CORPORATION (JP) | 1997-09-04 | — | — | WO | disclosed |
| US-5093358-A | MACROCYCLIC PLANT ACARICIDES | CIBA-GEIGY CORP. (US) | 1992-03-03 | — | — | US | disclosed |
| US-4315026-A | INSECTICIDES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1982-02-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110166043-A1 | BIOMARKER DETECTION-2 | CPB2, NAALAD2, PRSS2 | CHRM2 241/4885CHRM4 381/4885CHRM5 502/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.